Newbury, United Kingdom

James Andrew Leigh

USPTO Granted Patents = 2 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: James Andrew Leigh: Innovator in Biotechnology

Introduction

James Andrew Leigh is a notable inventor based in Newbury, GB. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for health-related challenges. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

One of his latest patents focuses on DNA encoding a plasminogen activating protein. This invention provides polynucleotide molecules that comprise nucleotide sequences encoding plasminogen activating (PauA) proteins and substantially homologous polypeptides, peptide fragments, and fusion proteins thereof. The invention also includes compositions and methods for recombinantly expressing the PauA proteins, as well as a vaccine designed to protect mammals against mastitis, utilizing the PauA protein or its derivatives.

Career Highlights

James Andrew Leigh has established a successful career at Pfizer Corporation, where he continues to innovate and contribute to the advancement of biotechnology. His work is characterized by a commitment to improving health outcomes through scientific research and development.

Collaborations

Throughout his career, James has collaborated with esteemed colleagues, including Everett Lee Rosey and Robert J Yancey, Jr. These partnerships have further enhanced the impact of his inventions and research.

Conclusion

James Andrew Leigh exemplifies the spirit of innovation in biotechnology, with his patents reflecting a dedication to addressing critical health issues. His contributions continue to influence the field and inspire future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…